Request Sample Inquiry
Minimally Invasive Glaucoma Surgery (migs) Devices Market

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

190

Base Year:

2023

Date

Aug - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2602

Segments Covered
  • By Product By Product Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Others
  • By Surgery Method By Surgery Method Trabecular Meshwork Bypass, Suprachoroidal Space Implants, Subconjunctival Space Implants, Schlemm’s Canal Implants, Gonioscopy-assisted Transluminal Trabeculectomy, Endocyclophotocoagulation
  • By End-use By End-use Hospitals, Ophthalmic Clinics, Others Surgical Centers
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 546.3 Million
Revenue 2032Revenue 2032: USD 887.2 Million
Revenue CAGRRevenue CAGR (2024 - 2032): 5.6%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Segment Analysis
    1. Overview
    2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, 2016 - 2028 (USD Million)
    3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - by Product
      1. By Valves
      2. By Glaucoma Drainage Implant
      3. By Glaucoma Tube Shunts
      4. By Stents
      5. By Others
    4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - by Surgery Method
      1. By Trabecular Meshwork Bypass
      2. By Suprachoroidal Space Implants
      3. By Subconjunctival Space Implants
      4. By Schlemm’s Canal Implants
      5. By Gonioscopy-assisted Transluminal Trabeculectomy
      6. By Endocyclophotocoagulation
    5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - by End-use
      1. By Hospitals
      2. By Ophthalmic Clinics
      3. By Others Surgical Centers
    6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Segment Analysis
    1. Overview
    2. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, 2016 - 2028 (USD Million)
    3. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
      1. By Valves
      2. By Glaucoma Drainage Implant
      3. By Glaucoma Tube Shunts
      4. By Stents
      5. By Others
    4. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery Method
      1. By Trabecular Meshwork Bypass
      2. By Suprachoroidal Space Implants
      3. By Subconjunctival Space Implants
      4. By Schlemm’s Canal Implants
      5. By Gonioscopy-assisted Transluminal Trabeculectomy
      6. By Endocyclophotocoagulation
    5. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End-use
      1. By Hospitals
      2. By Ophthalmic Clinics
      3. By Others Surgical Centers
    6. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
      1. U.S.
        1. U.S. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. U.S. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. U.S. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      2. Canada
        1. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      3. Mexico
        1. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Mexico Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
  5. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Segment Analysis
    1. Overview
    2. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, 2016 - 2028 (USD Million)
    3. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
      1. By Valves
      2. By Glaucoma Drainage Implant
      3. By Glaucoma Tube Shunts
      4. By Stents
      5. By Others
    4. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery Method
      1. By Trabecular Meshwork Bypass
      2. By Suprachoroidal Space Implants
      3. By Subconjunctival Space Implants
      4. By Schlemm’s Canal Implants
      5. By Gonioscopy-assisted Transluminal Trabeculectomy
      6. By Endocyclophotocoagulation
    5. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End-use
      1. By Hospitals
      2. By Ophthalmic Clinics
      3. By Others Surgical Centers
    6. Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
      1. Germany
        1. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      2. UK
        1. UK Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. UK Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. UK Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      3. France
        1. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      4. Spain
        1. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      5. Italy
        1. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      6. BENELUX
        1. BENELUX Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. BENELUX Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. BENELUX Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      7. Rest of Europe
        1. Rest Of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Rest Of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Rest Of Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
  6. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Segment Analysis
    1. Overview
    2. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
      1. By Valves
      2. By Glaucoma Drainage Implant
      3. By Glaucoma Tube Shunts
      4. By Stents
      5. By Others
    4. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery Method
      1. By Trabecular Meshwork Bypass
      2. By Suprachoroidal Space Implants
      3. By Subconjunctival Space Implants
      4. By Schlemm’s Canal Implants
      5. By Gonioscopy-assisted Transluminal Trabeculectomy
      6. By Endocyclophotocoagulation
    5. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End-use
      1. By Hospitals
      2. By Ophthalmic Clinics
      3. By Others Surgical Centers
    6. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
      1. China
        1. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      2. Japan
        1. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      3. India
        1. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      4. South Korea
        1. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      5. South East Asia
        1. South East Asia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. South East Asia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. South East Asia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Rest of Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Rest of Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
  7. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Segment Analysis
    1. Overview
    2. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, 2016 - 2028 (USD Million)
    3. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
      1. By Valves
      2. By Glaucoma Drainage Implant
      3. By Glaucoma Tube Shunts
      4. By Stents
      5. By Others
    4. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery Method
      1. By Trabecular Meshwork Bypass
      2. By Suprachoroidal Space Implants
      3. By Subconjunctival Space Implants
      4. By Schlemm’s Canal Implants
      5. By Gonioscopy-assisted Transluminal Trabeculectomy
      6. By Endocyclophotocoagulation
    5. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End-use
      1. By Hospitals
      2. By Ophthalmic Clinics
      3. By Others Surgical Centers
    6. Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
      1. Brazil
        1. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      2. Argentina
        1. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Argentina Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      3. Rest of Latin America
        1. Rest of Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Rest of Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Rest of Latin America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
  8. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Product
      1. By Valves
      2. By Glaucoma Drainage Implant
      3. By Glaucoma Tube Shunts
      4. By Stents
      5. By Others
    4. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Surgery Method
      1. By Trabecular Meshwork Bypass
      2. By Suprachoroidal Space Implants
      3. By Subconjunctival Space Implants
      4. By Schlemm’s Canal Implants
      5. By Gonioscopy-assisted Transluminal Trabeculectomy
      6. By Endocyclophotocoagulation
    5. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by End-use
      1. By Hospitals
      2. By Ophthalmic Clinics
      3. By Others Surgical Centers
    6. Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, by Country
      1. GCC Countries
        1. GCC Countries Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. GCC Countries Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. GCC Countries Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      2. South Africa
        1. South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. South Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Product
          1. By Valves
          2. By Glaucoma Drainage Implant
          3. By Glaucoma Tube Shunts
          4. By Stents
          5. By Others
        2. Rest of Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By Surgery Method
          1. By Trabecular Meshwork Bypass
          2. By Suprachoroidal Space Implants
          3. By Subconjunctival Space Implants
          4. By Schlemm’s Canal Implants
          5. By Gonioscopy-assisted Transluminal Trabeculectomy
          6. By Endocyclophotocoagulation
        3. Rest of Middle East & Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, By End-use
          1. By Hospitals
          2. By Ophthalmic Clinics
          3. By Others Surgical Centers
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Alcon Inc.
    2. Corza Ophthalmology
    3. Carl Zeiss Meditec AG
    4. Glaukos Corporation.
    5. Johnson & Johnson Vision
    6. AbbVie Inc. (Allergan Plc.)
    7. Katalyst Surgical
    8. Iridex Corporation
    9. Lumenis Ltd.
    10. Ziemer Ophthalmic Systems AG
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Minimally Invasive Glaucoma Surgery (MIGS) Devices valued at USD 546.3 Million in 2023 and is expected to reach USD 887.2 Million in 2032 growing at a CAGR of 5.6%.

  • The prominent players in the market are Alcon Inc., Corza Ophthalmology, Carl Zeiss Meditec AG, Glaukos Corporation., Johnson & Johnson Vision, AbbVie Inc. (Allergan Plc.), Katalyst Surgical, Iridex Corporation, Lumenis Ltd., Ziemer Ophthalmic Systems AG.

  • The market is project to grow at a CAGR of 5.6% between 2024 and 2032.

  • The driving factors of the Minimally Invasive Glaucoma Surgery (MIGS) Devices include

  • North America was the leading regional segment of the Minimally Invasive Glaucoma Surgery (MIGS) Devices in 2023.